Ferritin-guided iron supplementation in whole blood donors: Optimal dosage, donor Response and reTurn and Efficacy (FORTE) – a randomized controlled trial

FORTE

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON27514

Enrollment

2400

Registered

2020-05-07

Start date

2021-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-anaemic iron deficiency

Interventions

Iron supplementation

Eligibility

Inclusion criteria

Inclusion criteria: - The donors must meet all the standard requirements to donate - A ferritin measurement must be planned during the next donation - The baseline donation must be succesful - Ferritin level should be = 30 µg/L

Exclusion criteria

Exclusion criteria: - The donor does not master the Dutch language. - The donor is currently or has in the last 3 months been taking iron supplements prescribed by their doctor.

Design outcomes

Primary

Measure	Time frame
The primary outcome is the effects of four different iron supplementation protocols on ferritin and Hb levels and donor health, to placebo in donors with low ferritin levels.	—

Secondary

Measure	Time frame
The secondary outcome includes the difference in effects between different iron supplementation protocols	—

Contacts

Public ContactJan Karregat

Sanquin

J.Karregat@sanquin.nl0650093376

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)